Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
- Conditions
- Metabolic SyndromeSchizophrenia
- Registration Number
- NCT00569504
- Lead Sponsor
- Seoul National Hospital
- Brief Summary
The purpose of this study is to assess the cross-sectional prevalence of the metabolic syndrome in patients with schizophrenia taking antipsychotics.
- Detailed Description
Schizophrenic patients taking any kind of antipsychotics for at least 1 year at the Seoul National Hospital will be participated in this study.
we are planning to enroll approximately 1000 patients with schizophrenia.
For each subject
* abdominal circumference
* body mass index
* lipid profile : TG, HDL-chlo, total chol
* systolic/diastolic blood pressure
* fasting blood glucose will be measured.
we will calculate the rates of patients who meet the criteria for the Metabolic syndrome.
1. Abdominal obesity : absolute criteria
2. 2 or more of followings
1. Triglyceride ≥ 150mg/dL or ongoing treatment
2. HDL-cholesterol \< 40mg/dL (men) HDL-cholesterol \< 50mg/dL (female) or ongoing treatment
3. Hypertension 130mmHg ≥ systolic 85mmHg ≥ diastolic or ongoing treatment
4. FBS ≥ 100mg/dL or previous diagnosis of type II DM
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1000
- Patients taking a same antipsychotics at least more than one year
- schizophrenia or schizoaffective disorder
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method metabolic syndrome cross-sectional
- Secondary Outcome Measures
Name Time Method each factor of metabolic syndrome
Trial Locations
- Locations (1)
Seoul National Hospital
🇰🇷Seoul, Korea, Republic of